Literature DB >> 15350962

Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration.

Ludo Van Den Bosch1, Erik Storkebaum, Vicky Vleminckx, Lieve Moons, Ludo Vanopdenbosch, Wendy Scheveneels, Peter Carmeliet, Wim Robberecht.   

Abstract

Both in mice and humans, low expression levels of vascular endothelial growth factor (VEGF) are linked to adult-onset motor neuron disease or amyotrophic lateral sclerosis (ALS). The mechanism through which reduced VEGF levels result in this phenotype is unknown. We therefore examined the direct effects of VEGF on motor neurons and found VEGF to have a direct neurotrophic effect on motor neurons in vitro. Survival and vulnerability to excitotoxicity of motor neurons from VEGF(delta/delta) mice was however similar to that of motor neurons from non-transgenic littermates. The VEGF concentration in the spinal cord of mutant (G93A) SOD1 mice was not different from that found in wild-type SOD1 overexpressing mice. Upregulation of VEGF in the spinal cord, by housing mutant (G93A) SOD1 mice in hypoxic conditions, did not affect their life span. Our results show that VEGF is a neurotrophic factor for motor neurons in vitro, and shortage of this neurotrophic factor may contribute to the motor neuron death observed in humans and animals with low VEGF expression levels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15350962     DOI: 10.1016/j.nbd.2004.06.004

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  28 in total

1.  Vascular endothelial growth factor and fibroblast growth factor 2 delivery from spinal cord bridges to enhance angiogenesis following injury.

Authors:  Laura De Laporte; Anne des Rieux; Hannah M Tuinstra; Marina L Zelivyanskaya; Nora M De Clerck; Andrei A Postnov; Véronique Préat; Lonnie D Shea
Journal:  J Biomed Mater Res A       Date:  2011-05-31       Impact factor: 4.396

2.  Enhanced brain release of erythropoietin, cytokines and NO during carotid clamping.

Authors:  Stephana Carelli; Giorgio Ghilardi; Paola Bianciardi; Elisa Latorre; Federico Rubino; Marina Bissi; Anna Maria Di Giulio; Michele Samaja; Alfredo Gorio
Journal:  Neurol Sci       Date:  2015-10-22       Impact factor: 3.307

Review 3.  Motor neuron trophic factors: therapeutic use in ALS?

Authors:  Thomas W Gould; Ronald W Oppenheim
Journal:  Brain Res Rev       Date:  2010-10-21

Review 4.  Gene and protein therapies utilizing VEGF for ALS.

Authors:  Orion P Keifer; Deirdre M O'Connor; Nicholas M Boulis
Journal:  Pharmacol Ther       Date:  2013-10-29       Impact factor: 12.310

5.  Pathogenic cysteine mutations affect progranulin function and production of mature granulins.

Authors:  Jun Wang; Philip Van Damme; Carlos Cruchaga; Michael A Gitcho; Jose Manuel Vidal; Manuel Seijo-Martínez; Lei Wang; Jane Y Wu; Wim Robberecht; Alison Goate
Journal:  J Neurochem       Date:  2009-12-17       Impact factor: 5.372

6.  Spinal vascular endothelial growth factor induces phrenic motor facilitation via extracellular signal-regulated kinase and Akt signaling.

Authors:  Erica A Dale-Nagle; Irawan Satriotomo; Gordon S Mitchell
Journal:  J Neurosci       Date:  2011-05-25       Impact factor: 6.167

Review 7.  Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases.

Authors:  Nathan P Staff; David T Jones; Wolfgang Singer
Journal:  Mayo Clin Proc       Date:  2019-05       Impact factor: 7.616

8.  Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration.

Authors:  Koen Poesen; Diether Lambrechts; Philip Van Damme; Joke Dhondt; Florian Bender; Nicolas Frank; Elke Bogaert; Bart Claes; Line Heylen; An Verheyen; Katrien Raes; Marc Tjwa; Ulf Eriksson; Masabumi Shibuya; Rony Nuydens; Ludo Van Den Bosch; Theo Meert; Rudi D'Hooge; Michael Sendtner; Wim Robberecht; Peter Carmeliet
Journal:  J Neurosci       Date:  2008-10-15       Impact factor: 6.167

Review 9.  VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration.

Authors:  Peter Carmeliet; Carmen Ruiz de Almodovar; Ruiz de Almodovar Carmen
Journal:  Cell Mol Life Sci       Date:  2013-03-12       Impact factor: 9.261

Review 10.  Vascular endothelial growth factor: a neurovascular target in neurological diseases.

Authors:  Christian Lange; Erik Storkebaum; Carmen Ruiz de Almodóvar; Mieke Dewerchin; Peter Carmeliet
Journal:  Nat Rev Neurol       Date:  2016-07-01       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.